FHIR IG analytics| Package | hl7.fhir.uv.emedicinal-product-info |
| Resource Type | ClinicalUseDefinition |
| Id | ClinicalUseDefinition-cud-diflucan-renal.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ClinicalUseDefinition cud-diflucan-renal
Profile: ClinicalUseDefinition Warning (ePI)
identifier: http://example.org/identifier/cud-diflucan-renal
type: Warning
category: Warning
status: Active
population: Renal impairment (CrCl ≤ 50 mL/min)
| Code |
| For multiple-dose therapy, after a normal loading dose, give 50% of the recommended daily dose when CrCl ≤ 50 mL/min (no haemodialysis); give 100% of the recommended dose after each haemodialysis session. Single-dose therapy needs no adjustment. This rule applies to every multiple-dose indication. |
{
"resourceType": "ClinicalUseDefinition",
"id": "cud-diflucan-renal",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"identifier": [
{
"system": "http://example.org/identifier",
"value": "cud-diflucan-renal"
}
],
"type": "warning",
"category": [
{
"coding": [
{
"system": "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code": "warning",
"display": "Warning"
}
]
}
],
"subject": [
{
"reference": "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-diflucan"
}
],
"status": {
"coding": [
{
"system": "http://hl7.org/fhir/publication-status",
"code": "active",
"display": "Active"
}
]
},
"population": [
{
"reference": "Group/group-diflucan-renal",
"display": "Renal impairment (CrCl ≤ 50 mL/min)"
}
],
"warning": {
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "723188008",
"display": "Renal insufficiency"
}
],
"text": "For multiple-dose therapy, after a normal loading dose, give 50% of the recommended daily dose when CrCl ≤ 50 mL/min (no haemodialysis); give 100% of the recommended dose after each haemodialysis session. Single-dose therapy needs no adjustment. This rule applies to every multiple-dose indication."
}
}
}